Why did my GLP-1 stop working? Often the medication has not stopped working. An underlying driver nobody tested for is working against it and the prescriber who adjusts the dose every month has usually never drawn the labs that would show what changed. Plateaus are expected on every GLP-1 and the difference between a plateau that resolves and one that drags on is whether anyone asks why.
- Plateaus are normal on GLP-1 medication and not automatically a reason to raise the dose.
- The most common hidden cause is an untested driver such as insulin resistance, thyroid dysfunction, PCOS, sleep or menopause transition.
- The right response to a plateau is testing, not guessing.
- Our clinical rule is that a GLP-1 is not automatically increased every month because a higher dose exists on the schedule.
- The quarterly labs inside the $299/month membership help the clinician identify the drivers working against the medication.
Why plateaus happen on GLP-1s
The trials establish what good looks like. In STEP 1, semaglutide produced about 15% average weight loss at 68 weeks and in SURMOUNT-1, tirzepatide produced up to about 22.5%, with individual results varying. Nobody in those trials lost weight indefinitely. The body adapts, appetite returns to a new set point and the curve flattens. That flattening is expected physiology.
What separates a plateau that passes from one that persists is whether the plateau is happening on top of an unaddressed driver:
- Insulin resistance. High fasting insulin works against weight loss and responds to its own treatment, not to a higher dose of the same medication.
- Thyroid dysfunction. A thyroid that is in range by population standards but not right for you slows the whole metabolic picture.
- PCOS and hormonal drivers. Our clinical position is that a GLP-1 given to someone with PCOS may fight an unaddressed cause.
- Sleep and stress. Poor sleep and elevated cortisol drive cravings and insulin resistance independently of appetite.
- Menopause transition. For women in perimenopause or menopause, hormonal change changes the same metabolic picture the medication is working on.
- Unmanaged side effects. Nausea, reflux, muscle loss and fatigue nobody is working up make the plan harder to sustain than the plateau itself.
What the dose-escalation reflex misses
Some prescribers respond to a plateau with the next dose on the schedule.
Our clinical rule is the opposite: a GLP-1 is not automatically increased every month because a higher dose exists on the dosing schedule. A dose increase is a clinical decision that should follow evidence that the underlying picture supports it, not a calendar. If the plateau is driven by insulin resistance or PCOS or thyroid, a higher dose of the same medication treats the symptom and leaves the cause untouched.
The honest test for any prescriber you work with: ask them what they would draw before they raised your dose. If the answer is nothing, they are escalating on a schedule and not on evidence.
What to test before the dose moves
The panel that answers the plateau question is specific and inexpensive relative to the medication it protects.
Markers that answer the plateau question
What each one tells you
| Marker | What it tells you at a plateau |
|---|---|
| Fasting Insulin | Whether insulin resistance is working against the medication |
| Hemoglobin A1c (HbA1c) | Where blood sugar has actually moved over three months |
| TSH With Reflex To Free T4 | Whether thyroid drift is slowing the metabolic picture |
| Sex hormones, ordered by the clinician when there is a reason | Whether PCOS, menopause or low testosterone is part of the picture |
| Hs-CRP | Whether inflammation is complicating the response |
| Weight and symptom trend | Whether the clinician needs to look further at the plan |
Our quarterly Cardiometabolic Optimization Panel includes Fasting Insulin, Hemoglobin A1c (HbA1c), TSH With Reflex To Free T4 and Hs-CRP. Sex hormones are ordered by the clinician when there is a reason and are billed by the lab at its own rates.


The objections a discerning buyer raises
'My prescriber already manages my dose. Why would I pay twice?' Because dose management without testing is escalation on a schedule. Bring your prescription. If the clinician accepts you into care, you do not have to start over. Labs come first and the clinician decides with you, without a forced restart.
'Will you keep me on my current medication?' Yes, when the clinician judges it clinically indicated. Medication is billed separately by the pharmacy at pharmacy cost and the $299/month fee does not change when your prescription or your dose changes. Our GLP-1 is branded and FDA-approved, never compounded.
'Is a $299 membership worth it if my plateau resolves itself?' It may be, because a later plateau will also call for labs. The value of the membership is not one workup. It is a clinical team that reads the trend every quarter and knows where you started.
The value of the membership is not one workup. It is a clinical team that reads the trend every quarter and knows where you started.
'What if the labs show nothing?' Then the plateau is adaptive and patience, protein and resistance training carry you through it, with a clinician who confirms that rather than a dose escalation that hides it.
When the plateau is a signal to change the plan
A plateau with worsening fatigue, rising A1c, new reflux, hair loss or muscle loss is not a plateau. It is a signal that the plan needs to change and it needs a clinician who can see the whole picture rather than a prescriber who can only see the dose. The membership structure exists so that signal lands in front of someone who can act on it.
If you want to understand how the first quarter works before you join, our guide on what happens in your first 90 days of membership walks through it step by step.
FAQ
Why did my GLP-1 stop working?
Plateaus are common and expected. Weight loss naturally slows as the body adapts and the most common reason a GLP-1 appears to stop working is that an underlying driver such as insulin resistance, thyroid dysfunction, PCOS, sleep or menopause transition was never tested for and is working against the medication.
Should my dose be increased when I plateau?
Not automatically. A clinician who treats a plateau as a dose problem is guessing. The right response is to test for what changed: insulin resistance, thyroid, sleep, menopause transition or side effects that nobody is managing. Our clinical rule is that a GLP-1 is not automatically increased every month because a higher dose exists on the schedule.
Could PCOS be the reason my GLP-1 stalled?
It can be. A clinician can prescribe the medication and miss the insulin resistance or hormonal picture behind it and the medication will fight an unaddressed driver. Testing fasting insulin, androgens and thyroid alongside the GLP-1 identifies whether an underlying cause is working against the dose.
How do you know if a plateau is normal or a problem?
A clinician looks at the trend, not a single weigh-in. If weight has been stable for several weeks after steady loss, that can be a normal adaptive plateau. If the plateau comes with rising A1c, worsening fatigue, new symptoms or unmanaged side effects, it needs workup rather than a higher dose.
What labs matter at a plateau?
Fasting insulin, HbA1c, thyroid markers and, for the right patient, hormone panels. These identify the drivers working against the medication. Our Biomarker Audit every 90 days includes all of these inside the $299/month membership.
Will you make me switch medications?
No. Bring your current prescription. Labs come first, the clinician decides with you and there is no forced restart. Medication is billed separately by the pharmacy at pharmacy cost and the $299/month fee does not change with your dose.
Do GLP-1s work forever?
No medication works forever and no trial showed indefinite loss. In STEP 1, semaglutide produced about 15% average weight loss and in SURMOUNT-1, tirzepatide produced up to about 22.5%, with individual results varying. Long-term success depends on what surrounds the medication, not on the dose.
What does the plateau actually mean for my plan?
A plateau is information. A clinician who reads it alongside your labs and history decides whether the plan needs adjustment, whether a driver needs treatment or whether the plateau is a normal adaptive pause that patience and protein will carry you through.
One last thing
Before you accept a dose increase at your next plateau, ask one question: what would you draw before you raise it? The answer tells you whether you have a clinician or a schedule.
Related Guides
- What happens in your first 90 days of membership
- How much does a fasting insulin test cost?
- Is a DEXA scan necessary before starting a GLP-1 program?
- What does a direct primary care membership include?
References
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/